Jenny Goudemand Selected Research

Type 1 von Willebrand Disease

1/2020	Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms.
3/2013	VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
11/2010	The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
5/2008	Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
4/2008	Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
4/2007	Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques.
1/2007	Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jenny Goudemand Research Topics

Disease

18	Hemorrhage 01/2022 - 04/2002
11	Hemophilia A (Haemophilia) 11/2020 - 07/2003
8	von Willebrand Diseases (von Willebrand's Disease) 04/2022 - 03/2004
7	Type 1 von Willebrand Disease 01/2020 - 01/2007
7	Type 2 von Willebrand Disease 12/2019 - 06/2002
5	Aortic Valve Stenosis (Aortic Stenosis) 07/2016 - 07/2003
4	Type 3 von Willebrand Disease 01/2022 - 01/2020
2	Epistaxis (Nosebleed) 01/2020 - 04/2002
2	Hemophilia B (Haemophilia B) 05/2019 - 07/2015
2	Aortic Valve Insufficiency (Aortic Regurgitation) 07/2016 - 03/2015
2	Thrombasthenia (Glanzmann Thrombasthenia) 05/2015 - 03/2010
1	Angiodysplasia 01/2021
1	Hemarthrosis 01/2020
1	Menorrhagia 01/2020
1	Thrombocytopenia (Thrombopenia) 12/2019
1	Vascular System Injuries 03/2016
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2012
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2009
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2008
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2007
1	Pathologic Constriction (Stenosis) 07/2003

Drug/Important Bio-Agent (IBA)

26	von Willebrand FactorIBA 04/2022 - 06/2002
11	Factor VIII (Coagulation Factor VIII)IBA 04/2022 - 06/2002
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2007
4	Hemostatics (Antihemorrhagics)IBA 01/2020 - 07/2003
3	AntigensIBA 01/2020 - 03/2007
3	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 03/2013 - 03/2004
3	Biological ProductsIBA 04/2008 - 04/2002
2	Glycoproteins (Glycoprotein)IBA 03/2016 - 06/2006
2	CollagenIBA 03/2013 - 07/2003
2	factor VII clotting antigenIBA 07/2003 - 04/2002
1	IsoantibodiesIBA 07/2021
1	Capsules (Microcapsules)IBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 11/2020
1	A-factor (Streptomyces)IBA 01/2020
1	emicizumabIBA 09/2019
1	Factor V (Coagulation Factor V)IBA 08/2019
1	Fibrinogen (Factor I)FDA Link 05/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 05/2019
1	Neutralizing AntibodiesIBA 01/2018
1	Adenosine Diphosphate (ADP)IBA 07/2016
1	Factor XIII (Coagulation Factor XIII)IBA 01/2016
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 07/2015
1	IntegrinsIBA 05/2015
1	Proteins (Proteins, Gene)FDA Link 11/2014
1	Messenger RNA (mRNA)IBA 03/2010
1	Fibrinogen ReceptorsIBA 03/2010
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 03/2010
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2009
1	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 06/2006
1	ImmunosorbentsIBA 06/2006
1	EnzymesIBA 06/2006
1	Rituximab (Mabthera)FDA Link 01/2006
1	CoagulantsIBA 03/2004
1	Factor VIIa (Activated Factor VII)IBA 07/2003
1	recombinant FVIIa (rFVIIa)FDA Link 07/2003
1	Factor VII (Proconvertin)IBA 04/2002

Therapy/Procedure

4	Therapeutics 01/2021 - 04/2002
2	Transcatheter Aortic Valve Replacement 07/2016 - 03/2015
2	Heart-Assist Devices 01/2016 - 03/2015
1	Argon Plasma Coagulation 01/2021
1	Ligation 01/2020
1	Tooth Extraction (Tooth Extractions) 01/2020
1	Prostheses and Implants (Prosthesis) 07/2003
1	Minor Surgical Procedures (Minor Surgery) 04/2002